Skip to main content
Premium Trial:

Request an Annual Quote

Ultivue, University of Bern Strike Collaboration Deal for Spatial Biomarker Analysis Tech

NEW YORK — Ultivue, a provider of multiplex biomarker assays for tissue phenotyping and digital pathology, said on Thursday that it has struck a deal to provide reagents to the University of Bern's Translational Research Unit (TRU) for use in spatial biomarker analysis.

The TRU offers human and animal tissue-related services involving histology, tissue visualization, digital pathology, image analysis, and the construction of next-generation tissue microarrays, dubbed ngTMAs, for cancer research and other applications.

Under the terms of the deal, TRU will use Ultivue's reagents for multiplexed immunofluorescence in its tissue microarray pipeline. Ultivue will also collaborate with TRU to investigate the relevance of the tumor microenvironment by characterizing clinically well-annotated cohorts, according to the Cambridge, Massachusetts-based company.

Additional terms of the agreement were not disclosed.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.